← Back to Search

Observational for Breast Cancer

N/A
Recruiting
Led By Nimmi S Kapoor, MD
Research Sponsored by Jonsson Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing cryoablation for breast cance
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five years from last participant enrollment
Awards & highlights

Study Summary

This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five years from last participant enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and five years from last participant enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prospectively track patients who undergo cryoablation for breast cancer and record post-treatment related events.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients have their medical records reviewed on study.

Find a Location

Who is running the clinical trial?

Jonsson Comprehensive Cancer CenterLead Sponsor
361 Previous Clinical Trials
27,712 Total Patients Enrolled
24 Trials studying Breast Cancer
1,758 Patients Enrolled for Breast Cancer
Nimmi S Kapoor, MDPrincipal InvestigatorUCLA / Jonsson Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~64 spots leftby Jan 2025